News | April 07, 2024
LANXESS showcases extensive portfolio for the cosmetics industry at in-cosmetics Global
Highly effective preservation solutions ensuring the safety and protection of personal care products
Highly effective preservation solutions ensuring the safety and protection of personal care products
Abecma tripled progression-free survival compared to standard regimens in the Phase 3 KarMMa-3 trial
New leadership team announced at NATHEALTH Annual General Meeting 2024
Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities
The company has now received 100% of the incentive owed to the company for the financial year 2022-23 under the PLI scheme
For the treatment of stenotic lesions of arteriovenous fistula in the haemodialysis management of chronic renal failure
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Under this agreement, lpca will grant to Omexa a non-exclusive right to research, develop, manufacture and market an anti-cancer biosimilar for the global market
The facility will manufacture tablets, capsules, and injections for the oncology segment
Cipla will be responsible for the distribution of Sanofi India's six CNS brands including Frisium
Subscribe To Our Newsletter & Stay Updated
